A bottle of the ‘Coldrif’ cough syrup, manufactured by Tamil Nadu-based Sresan Pharmaceuticals, that has allegedly caused nearly two dozen deaths in southern Madhya Pradesh since September, 2025.
| Photo Credit: A.M. Faruqui
The Delhi government has banned the sale, purchase and distribution of Coldrif cough syrup after it was declared “not of standard quality”, an official order said.
According to the order issued on Friday (October 10, 2025), Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate Syrup), manufactured in May 2025 by Sresan Pharmaceutical Manufacturer, Tamil Nadu, was found to be adulterated with Diethylene Glycol (46.28% w/v), a toxic chemical known to be harmful to human health.
All stakeholders are directed to immediately stop selling, purchasing, or distributing the said batch of the syrup. The general public has also been advised not to use the product, given its potential health risks, the order said.
The assistance of all stakeholders is sought for the strict implementation and wide dissemination of the public advisory, which has been issued in public interest, it said.
Published – October 11, 2025 11:11 am IST
